Symposium 2022 Posters

Update on Clinical Evaluation of 3-[18F]fluoro-p-hydroxyphenethylguanidine ([18F]3F-PHPG) for Localization of Paraganglioma and Pheochromocytoma using Positron Emission Tomography (PET)

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Loss of epigenetic repression of retrotransposons in pancreatic neuroendocrine tumors

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Survival differences of lung neuroendocrine tumors in California by sociodemographic, clinicopathologic, and treatment factors

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

IgG4 related mesenteric fibrosis in small bowel neuroendocrine neoplasms

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Evaluation of Cases with Neuroendocrine Cell Hyperplasia for Classification as Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and Subsequent Whole Exome Sequencing Analysis

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

SV2A PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Neuroendocrine Tumors

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Mapping the gut microbiome in patients with small intestinal neuroendocrine tumors

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Evaluation of DOTATATE-PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs)

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Multiple endocrine neoplasia 4: genotype-phenotype association of germline CDKN1B variant type and site

Read More »

January 24, 2023 No Comments

Symposium 2022 Posters

Patient-Derived Organoids and their Potential for Precision Medicine in Neuroendocrine Tumors

Read More »

January 24, 2023 No Comments